Abstract

6069 Background: HIV+ patients (pts) are typically excluded from enrollment on randomized clinical trials for head and neck cancer. Data regarding clinical characteristics and outcomes for HIV+ pts...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call